首頁 ＞ 最新消息 > Patent Content of OncoLock Co. Ltd; [Updated: March 2024 by MIS: YM Chow]

[以下最新消息由 OncoLock CEO 簡靜香博士 獨家提供]

Patent Content of OncoLock Co Ltd;
豐宥科技股份有限公司

EXPRESS NEWS!!!

OncoLock Co. Ltd., has obtained the patent(s) approval of diagnosis of
"Human Ovarian Cancer" from the countries listed:

(1) European Union (17 Countries); Approval Dated 31.05.2023。 (certificate no. EP3686286)
(2) Japan (Certificate No. #7023942)。
(3) Singapore (Certificate No. #11202002529T)。
(4) Taiwan-ROC. (Certificate No. #1702400)
(5) China [專利号 ZL 2017 8 0051204.X, 授權公告号: CN 110036119 B]
(6) Hong-Kong (Approval)
(7) United Kindom (certificate no. EP3686286 )
(8) Thailand (published)

We are looking forward to welcoming qualified Bio-Tech Global Companies
to acquire our cutting-edge technologies to transfer the marvelous "Diagnostic Techniques".

[Oct 2023, All Rights Reserved.]